{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "CNBC"}, "author": "Sheila Chiang", "title": "Intel wants to build 'everybody's AI chips,' CEO says, as company plays catch-up with rivals - CNBC", "description": "Intel wants to regain leadership in the chip industry after losing market share opportunities to rivals, its CEO said.", "url": "https://www.cnbc.com/2024/06/05/we-want-to-build-everybodys-ai-chips-intel-ceo-talks-of-regaining-market-share.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/107424239-1717553354354-gettyimages-2155358471-TAIWAN_COMPUTEX.jpeg?v=1717553382&w=1920&h=1080", "publishedAt": "2024-06-05T07:14:36Z", "content": "Intel wants to regain its position as the world's leading chipmaker, CEO Pat Gelsinger said, after being overtaken by rivals TSMC and Samsung in recent years.\r\n\"We want to build everybody's chips, ev\u2026 [+2782 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Patrick Wingrove", "title": "Britain considers offering Lilly weight-loss drug on better terms than Wegovy - Reuters", "description": "Britain's medical costs regulator on Tuesday recommended Eli Lilly's weight-loss drug Mounjaro for some patients with obesity and suggested not placing a time limit on the medicine's use as it had for rival Novo Nordisk's Wegovy.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/britain-considers-offering-lilly-weight-loss-drug-better-terms-than-wegovy-2024-06-04/", "urlToImage": "https://www.reuters.com/resizer/v2/ZDLUTICHSBK6FKAOWJAUIV5BWQ.jpg?auth=a75f95ab942d681e688906a86cc33ad15c4c610548d053111ff70eb0341dccd8&height=1005&width=1920&quality=80&smart=true", "publishedAt": "2024-06-04T22:38:00Z", "content": null}]}